MIRM's third-quarter 2024 earnings and revenues surpass estimates. The company increases revenue guidance for 2024. Stock rises in pre-market.
Vous n'êtes pas connecté
IRWD's third-quarter earnings miss estimates while revenues beat the same. The company maintains revenue guidance for 2024. Stock falls.
MIRM's third-quarter 2024 earnings and revenues surpass estimates. The company increases revenue guidance for 2024. Stock rises in pre-market.
Agios' third-quarter 2024 earnings miss estimates while revenues match the same. Shares fall.
AEE's third-quarter earnings lag estimates, and revenues rise year over year by 5.5%. The company decreases its 2024 GAAP earnings guidance.
AMRN's third-quarter 2024 earnings meet estimates while revenues miss the same. Vascepa's sales in the United States decline year over year. Stock...
TTE's third-quarter earnings lag estimates, and revenues fall year over year by 11.9%. The company's outlook for 2024 remains unchanged.
CORT beats on both earnings and sales in the third quarter of 2024. The company increases the revenue guidance for 2024. Stock falls in after-hours...
FOLD's third-quarter 2024 earnings and sales beat the Zacks Consensus Estimate. The company raises its financial guidance for 2024.
BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.
BHC's third-quarter adjusted earnings and revenues beat estimates. The increase in revenue guidance is positive.
Puma Biotechnology beats third-quarter 2024 estimates for both the top and the bottom lines. The company updates its 2024 financial guidance. Stock...